On iOS App Store
300,000+
Subscribers
Heart disease continues to be the number one killer of women in the US. Micaela and cardiologist Dr. Stanley Liu review how we can all be doing more to prevent heart disease in women.
In this clip, we listen in on the beginning of a segment on “Fever of Unknown Origin”. Sol and Andi sit down with Mansi Desai, MD to find out what we know - and don’t know - about FUO.
Listen to Dr. Tiffany Proffitt and Nurse Practitioner Katy Vogelaar talk about the correct way to manage hives in the Urgent Care.
Listen to a selection of our conversations on how to use troponin levels to diagnose myocarditis.
Antibiotic stewardship matters—especially in urgent care. Emily Heil explains why we should all be paying attention.
You don’t need another lecture—you need practical learning that fits your life. Hippo delivers engaging content from clinicians who’ve been in your shoes, helping you build confidence and sharpen your skills without wasting your time.
Led by practicing clinicians, our courses go beyond checking the CME box—they challenge, inspire, and bring practical, high-impact learning that you can apply in the clinic, on the shift, and in the moment.
From on-the-go podcasts to bite-sized video courses, we make it easy to stay current, stay sharp, and keep learning—on your schedule, not ours.
Hippo Education is accredited with commendation by the ACCME, recognizing that we meet all core requirements and uphold the highest standards in CME.
If you work in primary care, chances are you’re talking about GLP-1 prescriptions for weight loss multiple times a day. Maybe you're explaining why Wegovy isn’t covered, managing labs and titration schedules, or helping a patient understand why they regained weight after stopping. It's a challenging landscape, and we’re all trying to keep up.
There was a time when prescribing continuous glucose monitors (CGMs) felt like an impossible ask unless your patient had type 1 diabetes or was on multiple daily insulin injections. Between the mountains of prior authorization paperwork and rigid insurance requirements, most of our patients with type 2 diabetes didn’t qualify — even if they were desperate for better data...
On November 10, 2025, the FDA announced a request to change to the labeling for menopausal hormone therapy (MHT). This was big news, and it has major ramifications for our patients.
